Berkshire Buybacks More Than Double to $9.6B in Q3 2026, but High Prices Question Value
Read source articleWhat happened
Berkshire Hathaway's Q3 2026 repurchases surged to $9.6 billion, more than double the $4.5 billion spent in Q2, signaling a significant step-up under Greg Abel's leadership. This acceleration follows the March 2026 formal restart of buybacks, which was initially framed as discretionary and closely watched as a test of Abel's capital allocation resolve. The master report had identified a $10B quarterly buyback print as a key catalyst that would increase conviction, and this nearly meets that threshold, though it falls just short. However, the stock is trading near all-time highs, raising questions about whether repurchases are value-accretive or simply a use of excess cash at elevated valuations. With $373B in cash and T-bills, the buyback pace still only absorbs a small fraction of liquidity, and the sustainability of this pace remains uncertain given management's emphasis on discretion.
Implication
While the Q3 repurchase surge is a clear step toward addressing the cash overhang, one quarter does not establish a durable program. The buyback amount still represents less than 3% of the cash hoard, and Berkshire's track record is to be highly opportunistic, so future quarters could see a pullback. At near all-time highs, the P/B multiple likely expanded beyond the 1.4x seen in the master report, reducing the absolute attractiveness of buybacks as a value-accreting tool. Investors should demand evidence of sustained repurchases across multiple quarters and ideally a concurrent decline in cash balances before upgrading the thesis. Until then, the base case of moderate buybacks remains intact, and the stock may be fairly valued at current levels, arguing for patience rather than aggressive accumulation.
Thesis delta
The thesis shifts modestly positive as the buyback acceleration nearly hits the bullish trigger of $10B, but falls short of confirming a durable program. The valuation increase to near all-time highs reduces the margin of safety, offsetting some of the per-share value accretion. Overall, the investment case remains a 'potential buy' but with lower conviction until multi-quarter evidence of sustained repurchases at reasonable prices emerges.
Confidence
Medium